Published in Pediatr Res on June 13, 2017
Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80
The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell (1996) 17.42
Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem (1962) 9.87
Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg (1978) 7.57
Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med (1999) 6.91
Breast milk and neonatal necrotising enterocolitis. Lancet (1991) 6.38
Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells (2001) 4.63
Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci (1994) 4.38
Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology (2004) 4.09
Necrotising enterocolitis. Lancet (2006) 3.94
The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med (1998) 3.70
The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol (2006) 2.83
A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol (2007) 2.77
Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology (2009) 2.64
Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A (2000) 2.61
Differential and regulated expression of C-X-C, C-C, and C-chemokines by human colon epithelial cells. Gastroenterology (1997) 2.37
Maternal rescue of transforming growth factor-beta 1 null mice. Science (1994) 2.28
Protection of the neonate by the innate immune system of developing gut and of human milk. Pediatr Res (2007) 2.18
Costs of necrotizing enterocolitis and cost-effectiveness of exclusively human milk-based products in feeding extremely premature infants. Breastfeed Med (2011) 2.12
Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research? Hum Reprod (2003) 2.09
Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol (2008) 1.99
The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats. Gut (2011) 1.92
Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol (2006) 1.83
Trophic effect of multiple growth factors in amniotic fluid or human milk on cultured human fetal small intestinal cells. J Pediatr Gastroenterol Nutr (2002) 1.77
Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol (2002) 1.75
Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med (2015) 1.74
The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock (2007) 1.65
Cytokine production by epithelial cells. FASEB J (1994) 1.60
Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest (2004) 1.59
Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis. J Pediatr Surg (2007) 1.57
Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res (2004) 1.52
The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg (1997) 1.47
Immunologic factors in human milk during the first year of lactation. J Pediatr (1982) 1.45
Impact of Donor Milk Availability on Breast Milk Use and Necrotizing Enterocolitis Rates. Pediatrics (2016) 1.44
Therapeutic effects of interleukin-4 gene transfer in experimental inflammatory bowel disease. J Clin Invest (1997) 1.44
TGF-β2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology (2010) 1.44
Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs (2008) 1.41
The role of PAF, TLR, and the inflammatory response in neonatal necrotizing enterocolitis. Semin Pediatr Surg (2005) 1.39
Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice. Gastroenterology (1995) 1.35
The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg (2001) 1.34
Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg (2005) 1.26
Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res (2003) 1.26
Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci U S A (2012) 1.24
Epithelial restitution in the gastrointestinal tract. J Clin Gastroenterol (1988) 1.19
Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2007) 1.15
Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes. J Matern Fetal Neonatal Med (2003) 1.12
Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2004) 1.12
Bile acids induce ileal damage during experimental necrotizing enterocolitis. Gastroenterology (2006) 1.11
The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect (1999) 1.08
Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse. Clin Invest Med (2001) 1.08
Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2010) 1.06
Physiology of amniotic fluid volume regulation. Clin Obstet Gynecol (1997) 1.06
Enteric defensin expression in necrotizing enterocolitis. Pediatr Res (1998) 1.05
Effect of breast milk and weaning on epithelial growth of the small intestine in humans. Gut (2002) 1.04
Why is epidermal growth factor present in the gut lumen? Gut (1996) 1.03
Erythropoietin acts as a trophic factor in neonatal rat intestine. Gut (2001) 1.01
Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis. Pathophysiology (2013) 1.00
Intestinal hormones and growth factors: effects on the small intestine. World J Gastroenterol (2009) 0.98
Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res (2007) 0.96
A study of gut immunity to enteral endotoxin in rats of different ages: a possible cause for necrotizing enterocolitis. J Pediatr Surg (2002) 0.96
Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut (2007) 0.95
Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut (2013) 0.94
Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol (1996) 0.94
Deep 16S rRNA metagenomics and quantitative PCR analyses of the premature infant fecal microbiota. Anaerobe (2012) 0.93
Necrotizing enterocolitis: a practical guide to its prevention and management. Paediatr Drugs (2006) 0.92
Does abnormal bile acid metabolism contribute to NEC? Semin Perinatol (2008) 0.91
Key nutrients and growth factors for the neonatal gastrointestinal tract. Clin Perinatol (2002) 0.89
Human β-defensin 2 expression in ELBW infants with severe necrotizing enterocolitis. Pediatr Res (2012) 0.88
Role of cytokines in human intestinal villous development. Clin Perinatol (2004) 0.88
Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine. Am J Clin Nutr (2000) 0.87
Interleukin-18 in human milk. Pediatr Res (2001) 0.87
Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor. Mucosal Immunol (2015) 0.87
SnapShot: the intestinal crypt. Cell (2013) 0.87
Effect of enteral IGF-1 supplementation on feeding tolerance, growth, and gut permeability in enterally fed premature neonates. J Pediatr Gastroenterol Nutr (2008) 0.86
Granulocyte colony-stimulating factor is present in human milk and its receptor is present in human fetal intestine. Pediatrics (2000) 0.86
Development of the infant intestine: implications for nutrition support. Nutr Clin Pract (2007) 0.86
IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin Immunol Immunopathol (1998) 0.86
Effects of interleukin-8 on the developing human intestine. Cytokine (2002) 0.85
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, and the soluble receptor osteoprotegerin in human gestational membranes and amniotic fluid during pregnancy and labor at term and preterm. J Clin Endocrinol Metab (2003) 0.85
Postnatal amniotic fluid intake reduces gut inflammatory responses and necrotizing enterocolitis in preterm neonates. Am J Physiol Gastrointest Liver Physiol (2013) 0.84
The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br J Nutr (2016) 0.83
Cryopreservation of amniotic fluid-derived stem cells using natural cryoprotectants and low concentrations of dimethylsulfoxide. Cryobiology (2011) 0.83
The interleukin-2-deficient mouse model. Pathobiology (2003) 0.82
The prenatal porcine intestine has low transforming growth factor-beta ligand and receptor density and shows reduced trophic response to enteral diets. Am J Physiol Regul Integr Comp Physiol (2009) 0.81
Ultrastructural anomalies in the fetal small intestine indicate that fetal swallowing is important for normal development: an experimental study. Virchows Arch A Pathol Anat Histopathol (1992) 0.81
Short- and long-term outcomes of necrotizing enterocolitis in infants with congenital heart disease. Pediatrics (2009) 0.80
Erythropoietin in human milk: physiology and role in infant health. J Hum Lact (2002) 0.80
Histologic and immunohistochemical features associated with outcome in neonatal necrotizing enterocolitis. Eur J Pediatr Surg (2013) 0.79
Functional characterization of the keratinocyte growth factor system in human fetal gastrointestinal tract. Pediatr Res (2000) 0.79
Amniotic fluid-borne hepatocyte growth factor protects rat pups against experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol (2014) 0.79
Enteral administration of a simulated amniotic fluid to very low birth weight neonates. J Perinatol (2005) 0.78
A decrease in the number of cases of necrotizing enterocolitis associated with the enhancement of infection prevention and control measures during a Staphylococcus aureus outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol (2011) 0.78
Evidence-based feeding strategies before and after the development of necrotizing enterocolitis. Expert Rev Clin Immunol (2014) 0.78
Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant. Clin Ther (2016) 0.78
Hematopoietic growth factors in neonatal medicine: the use of enterally administered hematopoietic growth factors in the neonatal intensive care unit. Clin Perinatol (2004) 0.78
Epidermal growth factor influences cell proliferation, glycoproteins, and lipase activity in human fetal stomach. Gastroenterology (1997) 0.78
Necrotizing enterocolitis and preterm infant gut bacteria. Semin Fetal Neonatal Med (2016) 0.77
Stem cells as a potential therapy for necrotizing enterocolitis. Expert Opin Biol Ther (2013) 0.77
Milk-borne epidermal growth factor modulates intestinal transforming growth factor-alpha levels in neonatal rats. Pediatr Res (2000) 0.77
Gastrointestinal cells of IL-7 receptor null mice exhibit increased sensitivity to irradiation. J Immunol (2001) 0.77